Why the study?
Does VKA continuation compared to NOACs affect bleeding and thromboembolic outcomes in stable AF patients?
Does VKA continuation compared to NOACs affect bleeding and thromboembolic outcomes in stable AF patients?
Even in well-selected AF patients with good INR control, VKA therapy is associated with an unacceptably high risk of major bleeding and poor bleeding outcomes.
Authors
No takes yet. Share an insight, caveat, or question.
Supports caution with VKA in stable AF despite good INR control; leaves open NOAC superiority for bleeding outcomes.
Michalski et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: